What is the prevalence of Floating-Harbor syndrome?

Floating-Harbor syndrome is an ultra-rare genetic disorder with fewer than 100 cases formally reported in medical literature, making it impossible to calculate a precise global prevalence. Because the condition is often underdiagnosed or misdiagnosed due to its variable clinical presentation, the true number of individuals living with Floating-Harbor syndrome is likely higher than currently documented in clinical databases.

Is Floating-Harbor syndrome considered a rare disease?

Yes, Floating-Harbor syndrome is classified as an ultra-rare condition. Due to the limited number of confirmed cases, an exact incidence rate—the number of new cases per year—has not been established. While medical literature has identified fewer than 100 cases worldwide, these statistics represent only those who have received a formal molecular diagnosis. The actual prevalence of Floating-Harbor syndrome is likely obscured by the diagnostic challenges associated with its characteristic features, such as short stature and delayed language development, which may be attributed to other, more common developmental disorders in early childhood.

Does Floating-Harbor syndrome affect genders or ethnicities differently?

Current clinical data does not suggest that Floating-Harbor syndrome has a predilection for any specific gender, ethnic group, or geographic region. Both males and females appear to be affected by the condition with equal frequency. Furthermore, Floating-Harbor syndrome has been reported in individuals from diverse ancestral backgrounds, indicating that the genetic mutations responsible for the syndrome are not confined to a specific population. As research into the SRCAP gene continues, experts remain vigilant for any evidence of population-specific clusters, though none have been identified to date.

What are the challenges in determining the prevalence of Floating-Harbor syndrome?

Estimating the true frequency of Floating-Harbor syndrome is complicated by several factors that are common in rare disease epidemiology:

• Diagnostic overshadowing: The clinical features of Floating-Harbor syndrome, such as expressive language delays and bone age maturation issues, may initially lead clinicians to pursue testing for more common syndromes.


• Access to genetic testing: Many individuals may remain undiagnosed because comprehensive genomic sequencing, necessary to identify the SRCAP gene mutation, is not universally accessible.


• Variable expressivity: The symptoms of Floating-Harbor syndrome can vary significantly between affected individuals, meaning some cases may present with mild symptoms that do not prompt a referral to a geneticist.


• Under-reporting: Many cases may be managed in primary care or community settings without being formally captured in clinical research registries or medical literature.

How does the DiseaseMaps community data inform our understanding?

While formal clinical literature provides the backbone of our medical knowledge, patient registries offer a vital, real-world perspective. Currently, 11 people with Floating-Harbor syndrome have joined the DiseaseMaps.org community and shared their lived experiences. This community-sourced data acts as a crucial complement to academic research, helping to bridge the gap between clinical statistics and the daily reality of those navigating life with this rare condition. Engaging with these peer-led networks can provide families with support and insights that are often unavailable in textbooks alone.

Next steps

• Consult a clinical geneticist to discuss genetic testing if you suspect Floating-Harbor syndrome.


• Connect with the DiseaseMaps.org community to share experiences with others impacted by this condition.


• Monitor the NIH GARD (Genetic and Rare Diseases Information Center) website for updates on new research and clinical trial opportunities.


• Keep a detailed medical history to assist specialists in tracking symptoms, which is essential for accurate clinical management.

Medical disclaimer: This information is for educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.

References

• Orphanet: Floating-Harbor syndrome (ORPHA:2079).


• NIH Genetic and Rare Diseases Information Center (GARD): Floating-Harbor syndrome.


• OMIM (Online Mendelian Inheritance in Man): Floating-Harbor Syndrome; FLHS (Entry #136140).


• PubMed: Clinical and molecular characterization of patients with Floating-Harbor syndrome.